Final Survival Follow-Up and Translational Associations Using Interval Indirect Immunization with Oregovomab (O) and Poly ICLC in Patients (pts) with Recurrent Platinum-Resistant Ovarian Cancer (PROC).
JOURNAL OF CLINICAL ONCOLOGY（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined